✦ LIBER ✦

Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues

✍ Scribed by D. Simon

Book ID: 105819675
Publisher: Springer
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 53
Category: Article
ISSN: 0012-186X
DOI: 10.1007/s00125-009-1572-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Similar risk of malignancy with insulin

✍ J. Rosenstock; V. Fonseca; J. B. McGill; M. Riddle; J. P. Hallé; I. Hramiak; P. 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 73 KB

Meta-analysis of individual patient data

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

✍ P. D. Home; A. Fritsche; S. Schinzel; M. Massi-Benedetti 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

Improving treatment satisfaction and oth

Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine

✍ C. Bradley; C. J. B. Gilbride 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Association of anAPOC3promoter variant w

Association of anAPOC3promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons

✍ M. van Hoek; T. W. van Herpt; A. Dehghan; A. Hofman; A. G. Lieverse; C. M. van D 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 153 KB

## Aims/hypothesis An __APOC3__ promoter haplotype has been previously associated with type 1 diabetes. In this population-based study, we investigated whether __APOC3__ polymorphisms increase type 2 diabetes risk and need for insulin treatment in lean participants. ## Methods In the Rotterdam St

Insulin glargine benefits patients with

Insulin glargine benefits patients with type 2 diabetes inadequately controlled on oral antidiabetic treatment: an observational study of everyday practice in 12,216 patients

✍ S. A. Schreiber; T. Haak 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Risk of malignancies in patients with di

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]

✍ U. Grouven; L. G. Hemkens; R. Bender; P. T. Sawicki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 71 KB